Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Berrino

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2022
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB TrialFilippo Pietrantonio, Paolo Manca, Sara Erika Bellomo, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
NPJ Precision Oncology|October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibitionGiorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist|March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomasEnrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Scientific Reports|July 25, 2023
Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohortGiovanna Chiorino, Elisabetta Petracci, Emir Sehovic, et al.
Cancer Cell|December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillanceVito Amodio, Simona Lamba, Rosaria Chilà, et al.
Genome Medicine|August 29, 2022
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomasEnrico Berrino, Laura Annaratone, Sara Erika Bellomo, et al.
Cancers|September 13, 2025
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic NeoplasmElena Crisà, Irene Dogliotti, Giuseppe Lia, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translationRaffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Journal of Translational Medicine|November 28, 2024
Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatmentSara Marchisio, Alessia Andrea Ricci, Gabriele Roccuzzo, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2022
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB TrialFilippo Pietrantonio, Paolo Manca, Sara Erika Bellomo, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
NPJ Precision Oncology|October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibitionGiorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist|March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomasEnrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Scientific Reports|July 25, 2023
Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohortGiovanna Chiorino, Elisabetta Petracci, Emir Sehovic, et al.
Cancer Cell|December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillanceVito Amodio, Simona Lamba, Rosaria Chilà, et al.
Genome Medicine|August 29, 2022
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomasEnrico Berrino, Laura Annaratone, Sara Erika Bellomo, et al.
Cancers|September 13, 2025
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic NeoplasmElena Crisà, Irene Dogliotti, Giuseppe Lia, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translationRaffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Journal of Translational Medicine|November 28, 2024
Monitoring circulating tumor DNA liquid biopsy in stage III BRAF-mutant melanoma patients undergoing adjuvant treatmentSara Marchisio, Alessia Andrea Ricci, Gabriele Roccuzzo, et al.
Pageof 6